PAVmed Inc.
PAVM· Nasdaq
Released May 21, 2020, after the close
10-Q filed May 28, 2020, 58 days after period end · 0001493152-20-010040
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$14.48M | -$3.54M | -$2.83M | -$4.27M |
| EPS Diluted | -$0.33 | -$0.13 | -$0.17 | -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR